# Antiplatelet Therapy Following Stent Implantation

> **NCT02051361** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 900 (actual)

## Conditions studied

- Acute Myocardial Infarction
- Coronary Syndrome
- Angina, Unstable

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02051361
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051361, "Antiplatelet Therapy Following Stent Implantation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02051361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*